-V Apostolopoulos Researcher Activity Profile

Research Author Detailed Information 

V Apostolopoulos Publication Rate By Year

V Apostolopoulos has published 1 paper(s) in 1994, 1 paper(s) in 1995, 1 paper(s) in 1996, 3 paper(s) in 2000, 1 paper(s) in 2001, 1 paper(s) in 2005, 2 paper(s) in 2006, 1 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

V V Apostolopoulos Author Information

LAST NAME: apostolopoulos

FIRST NAME: V

INITIALS: v

AFFILIATION:

Papers

V Apostolopoulos's Publication Record

1. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1. Year Published: 2000
The Austin Research Institute, Studley Rd, Heidelberg, Australia. g.pietersz@ari.unimelb.edu.au
2. Monoclonal antibodies to mucin VNTR peptides. Year Published: 2000
Austin Research Institute, Austin and Repatriation Medical Centre, Heidelberg, Australia.
3. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Year Published: 2000
The Austin Research Institute, Heidelberg, Australia. v.apostolopoulos@ari.unimelb.edu.au
4. MUC1 and breast cancer. Year Published: 2001
Austin Research Institute, Austin and Repatriation Medical Center, Studley Road, Heidelberg, VIC 3084, Australia. v.apostolopoulos@ari.unimelb.edu.au
5. Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies. Year Published: 1994
Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia.
6. Peptide epitopes in breast cancer mucins. Year Published: 1995
Austin Research Institute, Austin Hospital, Heidelberg, Vic., Australia.
7. Anti-peptide monoclonal antibodies to intestinal mucin 3. Year Published: 1996
Austin Research Institute, Heidelberg, Victoria, Australia.
8. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen. Year Published: 2005
Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
9. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. Year Published: 2006
Department of Medicine, Boston University School of Medicine, 650 Albany Street, Boston, MA 02118, USA.
10. Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide. Year Published: 2006
Burnet Institute at Austin, Immunology and Vaccine Laboratory, Heidelberg, VIC, Australia. eliadalzoura@hotmail.com
11. Gallium-diffused waveguides in sapphire. Year Published: 2007
12. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Year Published: 2008
Immunology and Vaccine Laboratory, Burnet Institute, Melbourne, Australia.
13. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Year Published: 2008
Immunology and Vaccine Laboratory, Burnet Institute, Melbourne, Australia.